Hypoglycemic Agents: all 3,927 studies that test it

Page 29 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.

• Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy SubjectsCompletedNCT01520831Phase 1
• Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With DiabetesCompletedNCT01520818Phase 3
• Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both MedicationsCompletedNCT01518101Phase 4
• MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 DiabetesCompletedNCT01517321Phase 3
• Pioglitazone to Treat Opioid Withdrawal SymptomsTerminatedNCT01517165Phase 1
• Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 DiabetesCompletedNCT01511172Phase 2
• Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin TabletsWithdrawnNCT01510522Phase 4
• Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes MellitusCompletedNCT01509001Phase 4
• A Study of Canagliflozin and Metformin Immediate Release (50 mg/500 mg) FDC Tablets in Healthy VolunteersCompletedNCT01508195Phase 1
• A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy VolunteersCompletedNCT01508182Phase 1
• Performance Evaluation of Blood Glucose Monitoring SystemsCompletedNCT01504620Phase 4
• Establishing Cardiovascular Biomarkers to Define Preferred Lantus® UseStatus unknownNCT01500850Phase 4
• Pharmacokinetics of Insulin Detemir in Healthy Chinese Male SubjectsCompletedNCT01498939Phase 1
• Comparison of Two Insulin Detemir Formulations in Healthy VolunteersCompletedNCT01498926Phase 1
• Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCompletedNCT01497600Phase 1
• Pharmacokinetics of Insulin Detemir in Healthy Volunteers From TaiwanCompletedNCT01497587Phase 1
• Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedNCT01497574Phase 1
• Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCompletedNCT01497561Phase 1
• Within-subject Variability of Insulin Detemir in Healthy VolunteersCompletedNCT01497535Phase 1
• Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 DiabetesCompletedNCT01497522Phase 3
• TAK-875 Glimepiride Drug-Interaction StudyCompletedNCT01496443Phase 1
• A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes MellitusCompletedNCT01495013Phase 3
• Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes MellitusCompletedNCT01493115Phase 1
• Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy VolunteersCompletedNCT01490658Phase 1
• Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy SubjectsCompletedNCT01490099Phase 1
• Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy VolunteersCompletedNCT01489644Phase 1
• Metformin in Obese Children and AdolescentsCompletedNCT01487993Phase 3
• Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy VolunteersCompletedNCT01487811Phase 1
• Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01487798Phase 4
• Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesCompletedNCT01486940Phase 3
• Comparison of Insulin Aspart Produced by Current Process and the NN2000 ProcessCompletedNCT01486914Phase 1
• Bioequivalence of Two Insulatard® Formulations in Healthy SubjectsCompletedNCT01486901Phase 1
• Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADsCompletedNCT01486862Phase 4
• Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 DiabetesCompletedNCT01486381Phase 3
• A Multiple Ascending Dose Study of ETC-1002 in Healthy SubjectsCompletedNCT01485146Phase 1
• The Effect of Central Insulin on Insulin Sensitivity and Energy MetabolismCompletedNCT01479075Phase 4
• Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate CancerWithdrawnNCT01478308Phase 2
• Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast CancerTerminatedNCT01477060Phase 2
• Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary SyndromeCompletedNCT01474967Not applicable
• Effects of Pioglitazone in Hypertensive PatientsCompletedNCT01472497Phase 4
• A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 DiabetesCompletedNCT01469143Phase 1
• Exploratory CSII Trial on Erectile Dysfunction in T2DM PatientsCompletedNCT01468519Phase 4
• Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 DiabetesCompletedNCT01467401Phase 4
• Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01467375Phase 3
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 DiabetesCompletedNCT01467323Phase 3
• Safety and Efficacy of Insulin Aspart in Children With Type 1 DiabetesCompletedNCT01467141Phase 4
• Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 DiabetesCompletedNCT01465152Phase 4
• Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's EsophagusCompletedNCT01465113Early Phase 1
• Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 DiabetesCompletedNCT01464099Phase 1
• A Study to Assess the Bioequivalence of 2 Fixed Dose Combination Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy VolunteersCompletedNCT01463774Phase 1
• Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP AxisCompletedNCT01461616Phase 3
• Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsCompletedNCT01459809Phase 3
• Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary SyndromeStatus unknownNCT01459445Not applicable
• Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With MetforminCompletedNCT01457911Phase 3
• R230C and C230C Variants of ABCA1 and Glyburide ResponseCompletedNCT01456650Phase 4
• Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly ParticipantsCompletedNCT01456117Phase 1
• A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 DiabetesCompletedNCT01455142Phase 1
• Glyburide (RP-1127) for Traumatic Brain Injury (TBI)CompletedNCT01454154Phase 2
• Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes MellitusCompletedNCT01452451Phase 2
• Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) TherapyCompletedNCT01452113Phase 2
• Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy VolunteersCompletedNCT01448070Phase 1
• Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's GranulomatosisTerminatedNCT01446211Phase 3
• Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination TherapyCompletedNCT01444248Phase 4
• Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.CompletedNCT01443221Phase 1
• Evaluation of Clinical Safety of Combining Metformin With Anticancer ChemotherapyCompletedNCT01442870Phase 1
• Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin ProducCompletedNCT01441869Phase 1
• A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 DiabeticsCompletedNCT01441232Phase 1
• Comparing Long-acting Insulins During Exercise in Type 1 DiabetesStatus unknownNCT01440439Phase 4
• Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic MarkersTerminatedNCT01440127Phase 1
• The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) TrialCompletedNCT01438723Phase 4
• Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous NoradrenalineCompletedNCT01435213Phase 1
• Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation TherapyTerminatedNCT01430351Phase 1
• Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes PatientsCompletedNCT01429818Phase 4
• Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With MetforminCompletedNCT01426802Phase 4
• The Swiss Glucose Variability StudyStatus unknownNCT01426737Phase 4
• Preventing Brain Injury in Infants With Congenital Heart DiseaseCompletedNCT01426542Phase 1
• Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male SubjectsCompletedNCT01426399Phase 1
• Liraglutide and Heart Failure in Type 2 DiabetesCompletedNCT01425580Phase 2
• Health Care for Type 1 Diabetes in Developing WorldCompletedNCT01424046Not applicable
• Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and AmenorrheaWithdrawnNCT01423487Not applicable
• Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and SitagliptinCompletedNCT01422590Phase 1
• The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 DiabetesCompletedNCT01420692Not applicable
• Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot StudyStatus unknownNCT01417897Phase 4
• Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male SubjectsCompletedNCT01415128Phase 1
• Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes MellitusCompletedNCT01414920Phase 2
• Drug-Drug Interaction Study With Metformin and NizatidineCompletedNCT01409395Phase 1
• A Trial to Investigate Efficacy and Usability of Published Best Practice to Control GlycaemiaCompletedNCT01407289Phase 4
• Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASHTerminatedNCT01406704Phase 4
• Best Timing of Insulin Bolus Before Meals of Different ContentsStatus unknownNCT01406496Not applicable
• Drug-drug Interaction Study With Metformin and ImatinibCompletedNCT01404715Phase 1
• A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma ConcentrationCompletedNCT01403818Phase 1
• A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy SubjectsCompletedNCT01402076Phase 1
• Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy SubjectsWithdrawnNCT01400802Phase 1
• Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Listro Mix 50/50® and Humalog Mix50/50® in Healthy SubjectsWithdrawnNCT01400789Phase 1
• The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1CompletedNCT01400191Phase 4
• Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT01399346Phase 1
• Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy SubjectsWithdrawnNCT01399255Phase 1
• Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 DiabeticsWithdrawnNCT01398670Phase 3
• Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering EfficacyCompletedNCT01398592Phase 4
• Pioglitazone and Metformin in Diabetic ChildrenCompletedNCT01396564Phase 1/2

← Hypoglycemic Agents overview